Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jun;18(6):e018235.
doi: 10.1161/CIRCIMAGING.125.018235. Epub 2025 Mar 31.

AI-Quantitative CT Coronary Plaque Features Associate With a Higher Relative Risk in Women: CONFIRM2 Registry

Affiliations
Observational Study

AI-Quantitative CT Coronary Plaque Features Associate With a Higher Relative Risk in Women: CONFIRM2 Registry

Gudrun M Feuchtner et al. Circ Cardiovasc Imaging. 2025 Jun.

Abstract

Background: Coronary plaque features are imaging biomarkers of cardiovascular risk, but less is known about sex-specific patterns in their prognostic value. This study aimed to define sex differences in the coronary atherosclerotic phenotypes assessed by artificial intelligence-based quantitative computed tomography (AI-QCT) and the associated risk of major adverse cardiovascular events (MACEs).

Methods: Global multicenter registry including symptomatic patients with suspicion of coronary artery disease referred for coronary computed tomography angiography. AI-QCT analyzed 16 coronary artery disease features. The primary end point was MACE defined as death, myocardial infarction, late revascularization, cerebrovascular events, unstable angina, and congestive heart failure.

Results: Among 3551 patients (mean age, 59±12 years; 49.5% women), MACE occurred in 3.2% of women and 6.1% of men during an average follow-up of 4.8±2.2 years. The AI-QCT features total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume were significantly higher in men (P<0.001), and high-risk plaques were more prevalent (9.2% versus 2.5%; P<0.0001). Independent of age and cardiovascular risk factors, the AI-QCT-derived features of total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume conferred a higher relative risk of MACE in women than men. For every 50-mm3 increase in total plaque volume, relative risk increased by 17.7% (95% CI, 1.12-1.24) in women versus 5.3% (95% CI, 1.03-1.07) in men (Pinteraction<0.001); for noncalcified plaque, relative risk increased by 27.1% (95% CI, 1.17-1.38) versus 11.6% (95% CI, 1.08-1.15; Pinteraction=0.0015); and for calcified plaque, relative risk increased by 22.9% (95% CI, 1.14-1.33) versus 5.4% (95% CI, 1.01-1.10; Pinteraction=0.0012), respectively. Similarly, for percentage atheroma volume, the risk was higher in women. The findings remained unchanged when restricted to a secondary composite end point (death and myocardial infarction).

Conclusions: The AI-QCT plaque features, total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume, conferred a higher relative MACE risk in women and may prompt more aggressive antiatherosclerotic therapy and reinforced preventive interventions.

Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04279496.

Keywords: artificial intelligence; atherosclerosis; computed tomography; computed tomography angiography; coronary artery disease; women’s health.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships that may be considered potential competing interests. Dr van Rosendael is a member of the Cleerly Scientific Advisory Board. Dr Pontone received an honorarium as a speaker/consultant and an institutional research grant from GE Healthcare, Bracco, Medtronic, and Novartis. Dr Buechel reports receiving speaking honoraria from GE Healthcare, Pfizer, Gilead, and IBA. Dr Gräni received funding from the Swiss National Science Foundation, InnoSuisse, the CAIM Foundation, the GAMBIT Foundation, and the Novartis Foundation for biomedical research, outside of the submitted work. Dr Choi is a consultant for Siemens, holds equity in Cleerly, and receives grant support from the George Washington Heart and Vascular Institute. Dr Rochitte reports receiving speaking honoraria for Pfizer, Edwards, GE, and Manole. Dr Khalique is a consultant for Edwards, Croivalve, and Restore Medical, holds equity in Triflo, and received honoraria for educational programs from Heartflow. Udo Hoffmann is an employee and equity holder in Cleerly, Inc, and received honoraria from Stanford University, Clinical Cardiovascular Sciences, Rapid AI, and MedTrace. Dr Danad is a member of the Cleerly Scientific Advisory Board. Dr Marques is a consultant for Cleerly, Inc. The other authors report no conflicts.

Figures

Figure 1.
Figure 1.
Predicted probability of major adverse cardiovascular event (MACE) in men vs women and forest plot. A, Predicted probability by noncalcified plaque (NCP) volume. The probability of MACE increased higher for women compared with men, with an increasing absolute NCP (mm3) above a threshold of 180 mm3. The outer borders delineate the 95% CIs. B, Hazard ratios per 50-mm3 increment artificial intelligence–based quantitative computed tomography plaque volume increase for risk of MACE in women vs men (adjusted for age and cardiovascular [CV] risk factors). CP indicates calcified plaque (volume); and TPV, total plaque volume.
Figure 2.
Figure 2.
Case examples. A, A 55-year-old woman with atypical chest pain and 2 cardiovascular risk factors (CVRFs): arterial hypertension, dyslipidemia, obesity, and hyperuricemia. Coronary computed tomography angiography (CTA) showed a noncalcified plaque (NCP) in the proximal left anterior descending (LAD) coronary artery (yellow arrow) with <50% diameter stenosis. Treatment with lipid-lowering therapy (statin+ezetimibe) and antihypertensive medication was initiated, and she remained event-free. Right, Artificial intelligence–based quantitative computed tomography (AI-QCT) plaque analysis showed an NCP volume of 155.4 mm3 (yellow box) and high-risk-plaque (HRP; red box) features. Note that color overlay (mid) facilitates the delineation of NCP and HRP. B, A 65-year-old woman with atypical chest pain, dyspnea, and a high coronary risk profile (5 CVRFs), smoking, arterial hypertension, positive family history, dyslipidemia, diabetes, and high lipoprotein A (89.1 ng/dL), who experienced major adverse cardiovascular event and underwent percutaneous coronary intervention (PCI) (LAD prox/mid/distal and right coronary artery [RCA]). Coronary CTA: white arrow pointing at calcified plaque in the proximal LAD. Mid, Curved multiplanar reformation. Right, AI-QCT plaque analysis revealed high total plaque volume (stage 3) with high calcified, high noncalcified plaque volume, and high percentage atheroma volume (39.2%).

Comment in

References

    1. Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Beaton AZ, et al. ; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. 2025 Heart Disease and Stroke Statistics: a report of US and global data from the American Heart Association. Circulation. 2025;151:e41–e660. doi: 10.1161/CIR.0000000000001303 - PubMed
    1. Rodriguez Lozano PF, Rrapo Kaso E, Bourque JM, Morsy M, Taylor AM, Villines TC, Kramer CM, Salerno M. Cardiovascular imaging for ischemic heart disease in women: time for a paradigm shift. JACC Cardiovasc Imaging. 2022;15:1488–1501. doi: 10.1016/j.jcmg.2022.01.006 - PMC - PubMed
    1. Pagidipati NJ, Coles A, Hemal K, Lee KL, Dolor RJ, Pellikka PA, Mark DB, Patel MR, Litwin SE, Daubert MA, et al. ; PROMISE Investigators. Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: insights from the PROMISE trial. Am Heart J. 2019;208:28–36. doi: 10.1016/j.ahj.2018.11.002 - PMC - PubMed
    1. Reynolds HR, Shaw LJ, Min JK, Spertus JA, Chaitman BR, Berman DS, Picard MH, Kwong RY, Bairey-Merz CN, Cyr DD, et al. ; ISCHEMIA Research Group. Association of sex with severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: secondary analysis of the ISCHEMIA randomized clinical trial. JAMA Cardiol. 2020;5:773–786. doi: 10.1001/jamacardio.2020.0822 - PMC - PubMed
    1. van Rosendael SE, Bax AM, Lin FY, Achenbach S, Andreini D, Budoff MJ, Cademartiri F, Callister TQ, Chinnaiyan K, Chow BJW, et al. Sex and age-specific interactions of coronary atherosclerotic plaque onset and prognosis from coronary computed tomography. Eur Heart J Cardiovasc Imaging. 2023;24:1180–1189. doi: 10.1093/ehjci/jead094 - PMC - PubMed

Publication types

Associated data